Name of Trust / logo

The place of gemcitabine and possible advantages over other intravesical drugs remains uncertain (49). Optimising intravesical chemotherapy One randomised trial has demonstrated that adapting urinary pH, decreasing urinary excretion and buffering the intravesical solution reduce the recurrence rate (50) . ................
................